Actimed Therapeutics
Ascot
About Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company focused on bringing innovation to the treatment of muscle wasting disorders to transform the care of an underserved and vulnerable patient population. The company produces anabolic/catabolic transforming agents to treat cachexia, an often deadly syndrome linked with a wide range of chronic illnesses, allowing healthcare providers to manage cancer-related cachexia. Actimed was founded in 2017 by Stefan Anker and Andrew Coats in Ascot, Windsor and Maidenhead.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $29.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2023)
- Website: actimedtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/actimed-therapeutics-55313 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.